In an illustrative board-style stem, a pregnant patient with profound thrombocytopenia, microangiopathic hemolytic anemia, and organ injury is not automatically a HELLP question. The board-level move is to name the syndrome first—pregnancy-associated thrombotic microangiopathy (TMA)—then identify the discriminator.
In a stem with severe thrombocytopenia, marked hemolysis, schistocytes, and an ADAMTS13 activity of 6%, the high-value clue is severe ADAMTS13 deficiency, a high-specificity finding that strongly supports TTP in the compatible clinical context. Mild transaminitis can occur in TTP; it should not outweigh this high-specificity result.
Start with the syndrome, not the pregnancy label
On the first pass, confirm three elements:
- Thrombocytopenia: How severe is it, and is there a prior platelet count for comparison?
- Microangiopathic hemolysis: Look for schistocytes, elevated LDH, low haptoglobin, indirect hyperbilirubinemia, reticulocytosis, and a negative direct antiglobulin test when provided.
- Organ injury: Is the dominant problem neurologic, renal, hepatic, cardiac, pulmonary, or obstetric?
Then ask what the stem has not told you. The supplied pattern does not provide blood pressure, proteinuria, baseline creatinine, baseline platelets, headache or visual symptoms, right-upper-quadrant pain, urine output, prior TTP, family history, or the postpartum course. Do not silently invent those facts.
Those omissions matter. Preeclampsia with severe features requires a hypertensive context, although proteinuria is not required when qualifying end-organ findings are present. ACOG severe-feature criteria include platelet count below 100 × 10⁹/L, creatinine above 1.1 mg/dL or doubling from baseline, liver transaminases more than twice the upper limit of normal or persistent severe right-upper-quadrant or epigastric pain, pulmonary edema, new-onset headache or visual symptoms meeting the relevant criteria, and severe-range blood pressure, defined as systolic blood pressure of at least 160 mm Hg or diastolic blood pressure of at least 110 mm Hg.
Those are severity criteria for hypertensive disease—not a synonym for HELLP and not a diagnostic requirement for TTP. For example, an AST only slightly above the laboratory reference range is not the ACOG liver threshold for a severe feature and, by itself, does not establish complete HELLP. It also does not exclude a partial or evolving HELLP phenotype.
Use ADAMTS13 as a discriminator, not decoration
A complete HELLP phenotype is classically defined by hemolysis, elevated liver enzymes, and low platelets. Partial or evolving HELLP patterns are described, but they should not be treated as interchangeable with complete HELLP. TTP and complement-mediated TMA can produce the same broad laboratory pattern, so the question is usually asking which clue has the greatest specificity.
| Feature | TTP | HELLP phenotype |
|---|---|---|
| Highest-yield clue | Severe ADAMTS13 deficiency, typically <10% of normal, in a compatible TMA | Hemolysis, elevated liver enzymes, and thrombocytopenia together; hypertension or proteinuria may be present but are not universal |
| Organ emphasis | Hematologic, neurologic, cardiac, or multiorgan ischemia may dominate | Hypertension or other preeclampsia features, hepatic injury, placental disease, and obstetric complications may be prominent |
| Expected response to delivery | Delivery does not correct the ADAMTS13 deficiency | The condition should generally begin improving after delivery; persistent or worsening severe TMA beyond the expected early postpartum course, particularly beyond 48–72 hours, should prompt diagnostic reconsideration |
| Board-level action | Urgent hematology involvement and plasma exchange-based treatment when suspicion is high | Obstetric stabilization, blood-pressure and seizure-risk management when indicated, and delivery planning |
An ADAMTS13 activity below 10% of normal strongly supports TTP when thrombocytopenia and microangiopathic hemolysis are present. It does not by itself distinguish immune-mediated from congenital TTP, and assay timing matters; ideally, the sample is obtained before plasma therapy.
Complement-mediated TMA, often termed atypical hemolytic uremic syndrome (aHUS) in clinical literature, rises on the differential when kidney injury is severe, renal-predominant, persistent, or worsening after delivery and ADAMTS13 is not severely deficient. It remains a diagnosis of exclusion. Renal involvement alone does not establish that diagnosis, because TTP and hypertensive disease can also affect the kidneys.
The management sentence that matters
If clinical suspicion for TTP is high, treatment should not wait several days for a send-out ADAMTS13 result. The practical board answer is to obtain the diagnostic sample before plasma-based therapy when feasible, involve hematology and transfusion medicine, and initiate urgent therapeutic plasma exchange with specialist-directed corticosteroid therapy. Delivery may be necessary for obstetric indications, but delivery alone is not the treatment for TTP.
Conversely, if a presumed HELLP presentation does not begin to improve after delivery or worsens postpartum—especially if severe thrombocytopenia, hemolysis, or kidney injury persists beyond approximately 48–72 hours—do not keep repeating the same label. Reopen the differential for TTP, complement-mediated TMA, disseminated intravascular coagulation, acute fatty liver of pregnancy, and other causes of hemolysis and organ injury.
The reasoning errors these MCQs punish
| Common error | Why it fails | Better repair |
|---|---|---|
| “Pregnancy plus low platelets equals HELLP.” | It anchors on context before identifying the syndrome. | Name TMA first, then compare ADAMTS13, organ pattern, timing, and response to delivery. |
| “Any AST elevation proves HELLP.” | It ignores thresholds and treats a supportive finding as decisive. | Check the degree of elevation, symptoms, blood pressure, and competing causes. |
| “ADAMTS13 is just another supportive test.” | Severe deficiency is a major discriminator in a compatible TMA. | Let high-specificity data outweigh several nonspecific abnormalities. |
| “Severe features, HELLP, and TTP are interchangeable.” | One is a hypertensive disease classification, one is a clinical phenotype, and one is an ADAMTS13-related TMA. | State the diagnostic category precisely before choosing management. |
MCQs that ask which statement is accurate often combine diagnosis, expected course, and treatment in one option. Read each option clause by clause. A statement that correctly identifies TTP but says delivery alone is definitive is still wrong.
Turn one question into retrieval practice
Rereading the explanation creates familiarity. Retrieval practice requires producing the contrast before looking at the answer. Use this seven-minute revision exercise after completing a question like this one:
- Minute 1: From memory, write the TMA triad and list the missing history or examination data that would affect the formulation.
- Minutes 2–3: Recreate a three-row comparison for TTP, HELLP, and complement-mediated TMA using only three headings: discriminator, dominant organ pattern, and immediate management signal.
- Minutes 4–5: Perturb the case. Change ADAMTS13 to a nonseverely reduced value, change the clinical picture to persistent severe postpartum kidney failure without another explanation, or add severe-range hypertension with transaminases above twice the upper limit. For each version, state the leading diagnosis and the next action.
- Minute 6: Write one sentence beginning with “The best answer is ___ because ___.” This exposes whether your reasoning depends on a threshold, a mechanism, or an assumption.
- Minute 7: Record one error in wording, not just the correct diagnosis: anchoring, threshold neglect, missing-history invention, or management mismatch.
Repeat the drill from a blank page 48–72 hours later. The goal is not to memorize a table; it is to recognize which variable changed and whether that change should alter the diagnosis, the urgency, or both.
Practical takeaways
- Start with TMA: thrombocytopenia, microangiopathic hemolysis, and organ injury.
- In a compatible presentation, ADAMTS13 activity below 10% strongly supports TTP.
- Complete HELLP requires hemolysis, elevated liver enzymes, and thrombocytopenia; partial or evolving patterns need careful labeling.
- ACOG severe-feature thresholds, the HELLP phenotype, and TTP are related but distinct concepts.
- Do not invent blood pressure, baseline renal function, neurologic symptoms, or postpartum response when a stem does not provide them.
- Suspected TTP requires urgent specialist-directed plasma exchange-based therapy; delivery alone is insufficient.
- Review these questions by changing one variable at a time and retrieving the reasoning from memory.